Logo Join | Forum| Help | Bookmark | Login
Submit New Story
Home Stories Groups People Marketplace | FREE Benefits
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a substantial proportion of liver diseases worldwide. Because the two viruses share similar modes of transmission, co-infection with the two viruses is not uncommon.

The exact number of patients co-infected with HCV and HBV is unknown. In patients with chronic hepatitis B, estimates of the rates of HCV co-infection vary from 9% to 30%. The primary concern with HBV/HCV co-infection is that it can lead to more severe liver disease and an increased risk for progression to liver cancer (HCC).

Treatment of HBV/HCV co-infected patients can represent a challenge. No standard recommendations exist for treatment of HBV/HCV co-infection, and therefore treatment must be individualized based on patient variables such as hepatitis blood test results and DNA or RNA levels, patient's prior exposure to antiviral treatment, and the presence of other similarly transmitted viruses such as hepatitis D virus and human immunodeficiency virus (HIV).
Tags: liver, hepatitis, hbv
Posted By: Internetdaze 2 months, 1 Week, 6 days, 11 hours, 7 minutes ago
All Votes: 4
Bookmark
Comments (3) | Who voted on this story (4) | Email this story
 

UnitedProject.org Inc. (c) 2006-2008 All content published on UnitedProject.org is provided for informational purposes only and is not meant to substitute for the advice, diagnosis or treatment provided by your physician or other healthcare professionals. If you think you are experiencing a medical problem or an emergency please contact your physician, local emergency room or call 911. Healthcare benefits and discounts are not insurance and not intended as a substitute for health insurance. Except when other source is cited, all content posted by members is licensed under Creative Commons Public Domain License.



Site last updated 05/08/08 - loaded in 0.3566 seconds